Atavistic Chemotherapy Clinical Trial

Write a Review301-760-7777

Patients are seen only once in our trial sites (see below), but all subsequent monitoring of the patient is carried out by their original oncologists in the city and country of the patient’s origin. Comprehensive blood chemistry and blood cell counts are requested every 15 to 20 days to monitor tolerance to the treatment. The monitoring of tumor response to treatment involving physical examination, radiological studies and/or tumor markers in blood are performed in the city and country of origin of the patient. Radiological images on CD or USB cards and their interpretations are sent by the patient via DHL or Fedex to be studied and recorded by Dr. Frank Arguello.